Skip to main content

Table 1 Baseline characteristics of resuscitated and control patients

From: Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation

  

CPR

Control

P value

  

n = 36

n = 20

 
   

%

 

%

 

Age (years)

 

63.9 ± 2.1

 

65.7 ± 2.5

 

0.58/ns

Gender

Male

28

78

16

80

0.85/ns

 

Female

8

22

4

20

 

Cause of CA or

Cardiac

23

64

20

100

<0.005

hospital admission

Non-cardiac

10

28

0

0

 
 

Unknown

3

8

0

0

 

Coronary angiography

 

23

64

12

60

0.78/ns

Location of CPR

out-of-hospital

27

75

   
 

in-hospital

9

25

   

Duration of CPR (min)

 

21.8 ± 2.5

    

No-flow time (min)

 

4.5 ± 0.8

    

Initial rhythm

VT/VF

20

56

   
 

Asystole/PEA

16

44

   

Outcome

Survival to discharge

14

39

20

100

 
 

GOS (survivors) at discharge

4.4 ± 0.2

 

5.0 ± 0.0

  
 

SOFA score day 1

11.0 ± 0.4

    
 

SOFA score day 2

10.6 ± 0.4

    

Medication at ICU

Vasopressors

20

56

0

0

<0.001

 

Thrombolysis

3

8

0

0

0.18/ns

 

GPIIb/IIIa blockers

16

44

2

10

< 0.001

 

Acetylsalicylic acid

25

69

15

75

0.66/ns

 

Clopidogrel

21

58

12

60

0.90/ns

Medication prior to event

Statins

8

22

12

60

<0.01

Consecutive organ

Acute renal failure

8

22

0

0

<0.05

failure

Acute liver failure

3

8

0

0

0.54/ns

 

Acute heart failure

4

11

0

0

0.29/ns

Co-morbidities

CAD

24

67

14

70

0.80/ns

 

PAD

4

11

5

25

0.26/ns

 

Chronic heart failure

2

6

3

15

0.34/ns

 

Chronic renal insufficiency

4

11

2

10

0.99/ns

 

Liver insufficiency

4

11

0

0

0.29/ns

 

Pulmonary disease

9

25

6

30

0.69/ns

Cardiovascular risk

Hypertension

16

44

15

75

<0.05

factors

Hyperlipidemia

6

17

11

55

<0.005

 

Diabetes

9

25

2

10

0.29/ns

 

Smoking

7

19

8

40

0.10/ns

Laboratory values

Leukocytes/μL (day 1)

15.5 ± 1.1

 

7.7 ± 0.5

 

<0.001

 

Leukocytes/μL (day 2)

13.7 ± 1.5

 

7.7 ± 1.0

 

<0.005

 

Platelets/μL (day 1)

203.7 ± 12.3

 

231.9 ± 12.9

 

0.12/ns

 

Platelets/μL (day 2)

183.9 ± 12.4

 

200.9 ± 41.0

 

0.7/ns

 

CRP mg/L (day 1)

37.2 ± 11.3

 

8.7 ± 2.9

 

<0.05

 

CRP mg/L (day 2)

56.8 ± 12.1

 

6.3 ± 1.4

 

<0.001

  1. Basic data of the cardiopulmonary resuscitation and the cardiological control group (Control). Both groups are comparable in baseline variables including age, gender, incidence of coronary artery disease, coronary angiography, congestive heart failure and other relevant secondary disorders. There are slight but significant differences in distribution of cardiovascular risk factors as well as co-medication.
  2. CA, cardiac arrest; CAD, coronary artery disease; CPR, cardiopulmonary resuscitation; CRP, C-reactive protein; GOS, Glasgow Outcome Scale; ns, statistically not significant; PAD, peripheral artery disease; PEA, pulseless electrical activity; SOFA, Sequential Organ Failure Assessment; VF, ventricular fibrillation; VT, ventricular tachycardia.